Friday, June 16, 2017 5:29:47 AM
"While the asset still faces a certain level of clinical and regulatory risk, we believe ND0612 is becoming sufficiently de-risked at this point to attract a potential M&A suitor. Our view is supported by recent reports stating that NDRM has retained a financial advisor for the possible sale of the company, according to Bloomberg."
https://www.streetinsider.com/Analyst+Comments/Oppenheimer+Upgrades+Neuroderm+Ltd+%28NDRM%29+to+Outperform%3B+Alleged+Takeover+Discussions+Pump+New+Life+into+ND0612/13009512.html
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM